New research finds that adults with schizophrenia spectrum disorders have high rates of comorbid mental and substance use disorders and significant social and economic disadvantages, and only 26% received minimally adequate treatment. Meeting the needs of people with schizophrenia spectrum disorders will require innovative interventions and implementation to improve access to and use of evidence-based approaches, the authors argue.
Read more: New research identifies critical gaps in mental health care for adults with schizophrenia spectrum...
Experts have developed a breakthrough small-molecule drug, a 'protein degrader'. This molecule, called ACBI3, could potentially lead to new therapies independent of KRAS mutation type, improving outcomes for all patients with cancers caused by KRAS mutations.
Read more: Potential breakthrough for hard to treat cancers
A study has uncovered new insights into how the brain processes and integrates pain information. The research goes beyond identifying brain areas that respond to pain, revealing the mechanisms behind the brain's integration of pain-related information. Using functional magnetic resonance imaging (fMRI), they formalized how the brain combines pain expectations with the actual intensity of painful stimuli.
Read more: How the brain integrates pain prediction and stimuli